Evidence map›Paper›PMID 41487969›Full record

ArticleJournal of inflammation research2025

The eNAMPT-Integrin α5β1 Axis Mediates Neutrophil-Endothelial Cell Interactions Driving Inflammation in Ulcerative Colitis.

Yongcheng Di, Wenbin Ji, Wenhao Xiong, Wenbin Song, Guoshan Chen, Danzhou Li, Feng Qi

Abstract read
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yongcheng Di *Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Wenbin Ji *Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Wenhao Xiong *Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Wenbin SongDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Guoshan ChenDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Danzhou LiDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
Feng QiDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.ORCID 0000-0001-5490-0985

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ulcerative colitis (UC), a chronic inflammatory bowel disease with rising global incidence, involves neutrophil-driven mucosal damage. The precise mechanisms remain elusive, hindering targeted therapies. Therefore, this study aims to integrate single-cell transcriptomics with in vivo experiments to reveal the key signaling axes driving pathogenic neutrophil activation in UC. Methods: Single-cell transcriptomics characterized UC inflammatory microenvironments, focusing on neutrophil functional states and intercellular interactions. Based on key findings from bioinformatics analysis, we hypothesize that the eNAMPT-integrin α5β1 signaling axis drives abnormal neutrophil-endothelial cell communication and functionally validate this hypothesis in in vivo models. Results: Neutrophils exhibited aberrant activation and significant Conclusion: The eNAMPT-integrin α5β1-mediated neutrophil-endothelial communication axis represents a novel pathogenic pathway in UC, providing a foundation for precision therapies targeting this mechanism.

Indexed as

bioinformaticsendothelial cellsNAMPTneutrophilsulcerative colitis

Identifiers

PMID41487969
PMCPMC12764215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.